Difficulty: Medium
Average Score: 66%
Testbank
A client is admitted to the hospital with acute hemorrhage from esophageal varices. What medication should the nurse anticipate administering that will reduce pressure in the portal venous system and control esophageal bleeding?
Correct answer
B
Rationale
Octreotide is the medication that should be administered to reduce pressure in the portal venous system and control esophageal bleeding. Octreotide is a somatostatin analogue that decreases portal pressure by inhibiting the release of various hormones, which leads to vasoconstriction of splanchnic blood vessels, effectively reducing the risk of further hemorrhage from esophageal varices.
A: Vitamin K is not relevant in this scenario as it primarily aids in blood coagulation and does not address the underlying portal hypertension causing the esophageal bleeding.
C: Vasopressin can cause vasoconstriction but is less specific than octreotide and may have significant adverse effects, making it a less favorable choice for managing portal hypertension in this context.
D: Epinephrine is mainly used for its vasoconstrictive properties in anaphylaxis or cardiac arrest situations, and it does not specifically target the portal venous system to control bleeding from esophageal varices.
A: Vitamin K is not relevant in this scenario as it primarily aids in blood coagulation and does not address the underlying portal hypertension causing the esophageal bleeding.
C: Vasopressin can cause vasoconstriction but is less specific than octreotide and may have significant adverse effects, making it a less favorable choice for managing portal hypertension in this context.
D: Epinephrine is mainly used for its vasoconstrictive properties in anaphylaxis or cardiac arrest situations, and it does not specifically target the portal venous system to control bleeding from esophageal varices.